Bionerviano Srl Società Benefit O In Breve Bion Srl S.b.
Dati societari di
Bionerviano Srl Società Benefit O In Breve Bion Srl S.b.
Affidabilità creditizia di
Bionerviano Srl Società Benefit O In Breve Bion Srl S.b.
Valuta la capacità di un soggetto di onorare gli impegni finanziari, aiutando a prevedere il rischio di inadempienza nei pagamenti.
Persone in Bionerviano Srl Società Benefit O In Breve Bion Srl S.b.
Iscriviti ora
gratuitamente
Accedi a tutte le informazioni di Bionerviano Srl Società Benefit…, di altre 6 milioni di imprese e 13 milioni di contatti con i prodotti Cerved pensati per te!
Descrizione di Bionerviano Srl Società Benefit O In Breve Bion Srl S.b.
Visit Accelera Teamat the SOT 2023 Annual Meeting in Nashville, TennesseeMarch 19 - 23Booth #1214Visit our booth for an overview of our services Nerviano, 19, October 2022_NMS Group S.p.A announced the appointment of Mr. Lincoln Pan to its Board of Directors, effective immediately."We are pleased to welcome my PAG colleague Lincoln to the NMS Group Board," said David Wong, chairman of NMS Group. "Lincoln's deep experience in increasing the value of our global investments with strong financial oversight will be invaluable to NMS Group as we continue to grow our business." Nerviano_October_1_2022_NerPharMa Srl, leading CMO and a member of the NMS Group today announced the change in its Board Composition, following the resignation of its board member Enrico Pesenti, effective today. Hugues Dolgos, Pharm.D., CEO of NMS Group, is appointed as Sole Director of NerPharMa Srl. January 12, 2023 - Nerviano Medical Sciences S.r.l., a part of NMS Group S.p.A. (NMS Group), focused on the discovery and early development of oncology drugs and the largest oncological R&D company in Italy, announced today the senior appointment to drive validation and maximize the value of its IDH1/IDH2 Inhibitor Asset, NMS-173, and facilitate its expanding and advancing clinical pipeline. Terrence West, MBA, joins as New Business, Virtual CEO. Accelera Srl, leading CRO and a member of the NMS Group today announced the change in its Board Composition, following the resignation of its board member Enrico Pesenti, effective today. Hugues Dolgos, Pharm.D., CEO of NMS Group, is appointed as Sole Director of Accelera Srl.
Parole chiaveAmbito Operativo
Il codice 71.12.10 (ATECO) descrive l'attività come: Attività degli studi di ingegneria.
Profilo Dimensionale
Bionerviano Srl Società Benefit O In Breve Bion Srl S.b. rientra nella classificazione "piccola impresa" (tra 10 e 49 dipendenti). Il capitale sociale ammonta a 50.2 M €. I dati economici più recenti si riferiscono all'anno 2024.
Aziende Simili
- Jacobs Italia S.p.a. • Milano, MI
- Lombardini22 S.p.a. Detta Anche In Breve L22 S.p.a. • Milano, MI
- Accenture Capital Projects And Engineering Services S.r.l. • Milano, MI
- Aecom Italia S.p.a. • Milano, MI
- Tecno In S.r.l. • Milano, MI
- Stantec S.p.a. • Segrate, MI
- Albert Engineering & Project S.r.l. • Milano, MI
- Nte Process Srl • Gorgonzola, MI
- Simeco S.p.a. • Milano, MI
- Studio 79 Societa' Di Ingegneria S.r.l. In Liquidazione • Milano, MI